JPH0135000B2 - - Google Patents
Info
- Publication number
- JPH0135000B2 JPH0135000B2 JP54110911A JP11091179A JPH0135000B2 JP H0135000 B2 JPH0135000 B2 JP H0135000B2 JP 54110911 A JP54110911 A JP 54110911A JP 11091179 A JP11091179 A JP 11091179A JP H0135000 B2 JPH0135000 B2 JP H0135000B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- group
- methyl
- quinolinesulfonyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 31
- 208000007536 Thrombosis Diseases 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- -1 8-quinolyl group Chemical group 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 238000007327 hydrogenolysis reaction Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000004019 antithrombin Substances 0.000 description 8
- 125000003710 aryl alkyl group Chemical group 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000005493 quinolyl group Chemical group 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 229960004072 thrombin Drugs 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- DNUTZBZXLPWRJG-UHFFFAOYSA-N 1-Piperidine carboxylic acid Chemical compound OC(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-N 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- ULEBESPCVWBNIF-BYPYZUCNSA-N L-arginine amide Chemical class NC(=O)[C@@H](N)CCCNC(N)=N ULEBESPCVWBNIF-BYPYZUCNSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- VHXJRLYFEJAIAM-UHFFFAOYSA-N quinoline-2-sulfonyl chloride Chemical compound C1=CC=CC2=NC(S(=O)(=O)Cl)=CC=C21 VHXJRLYFEJAIAM-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- XCMAYGDQKTWICK-UHFFFAOYSA-N 3-methylquinoline-8-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC2=CC(C)=CN=C21 XCMAYGDQKTWICK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 108010035369 Cohn fraction I Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- CHDFNIZLAAFFPX-UHFFFAOYSA-N ethoxyethane;oxolane Chemical compound CCOCC.C1CCOC1 CHDFNIZLAAFFPX-UHFFFAOYSA-N 0.000 description 1
- GHBNOCBWSUHAAA-UHFFFAOYSA-N ethyl 4-methylpiperidine-2-carboxylate Chemical compound CCOC(=O)C1CC(C)CCN1 GHBNOCBWSUHAAA-UHFFFAOYSA-N 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01Q—ANTENNAS, i.e. RADIO AERIALS
- H01Q1/00—Details of, or arrangements associated with, antennas
- H01Q1/08—Means for collapsing antennas or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Description
æ¬çºæã¯ãæ°èŠãªN2âã¢ãªãŒã«ã¹ã«ããã«â
âã¢ã«ã®ãã³ã¢ããé¡åã³è¬å€ãšããŠèš±å®¹ãã
åŸããã®å¡©ã«é¢ãããæŽã«è©³ããã¯ãåªããæã
ãã³ãã³äœçšãæãããã€ãæ¯æ§ã®å°ãªãN2â
ã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢ããé¡å
ã³è¬å€ãšããŠèš±å®¹ããåŸããã®å¡©ã«é¢ããã åŸæ¥ãããè¡æ çã®åªããæ²»çè¬ãåŸãããšã
ãå€ãã®è©Šã¿ããªãããŠãããããã®ã²ãšã€ãšã
ãŠãN2âïŒïœâããªã«ã¹ã«ããã«ïŒââã¢ã«
ã®ãã³ãšã¹ãã«é¡ãè¡æ ã溶解ããããšã¯ãç¥ã
ããŠããïŒç±³åœç¹èš±3622615ïŒã ãŸããæ¬çºæè çã¯ãæ¢ã«ãããçš®ã®N2âã¢
ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢ããé¡ãã
ãšãã°N2âãã³ã·ã«ââã¢ã«ã®ãã³ãšã¹ãã«
åã¯ã¢ããé¡ãéžææ§ã®é«ãæããã³ãã³äœçšã
æããè¡æ çã®æ²»çè¬ãšããŠæçšãªååç©ã§ãã
ããšãèŠãåºããŠãããããããããäœæ¯æ§ã§ã
éžææ§ã®é«ãæããã³ãã³å€ã®éçºãæãŸããŠã
ãã æ¬çºæè çã¯ãN2âã¢ãªãŒã«ã¹ã«ããã«â
âã¢ã«ã®ãã³ã¢ããé¡ã«å å«ãããïŒâãN2â
ïŒïŒâã¢ã«ãã«âïŒïŒïŒïŒïŒïŒïŒâããã©ããã
âïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ã
âïŒâãããªãžã³ã«ã«ãã³é žé¡åã³è¬å€ãšããŠèš±
容ããåŸããã®å¡©ããåŸæ¥å ¬ç¥ã®ååç©ã«æ¯ãã
é«ãæããã³ãã³äœçšãæãããšãšãã«ãäœæ¯æ§
ã§ããããšãèŠãåºããã æ¬çºæååç©ã§ããN2âã¢ãªãŒã«ã¹ã«ããã«
ââã¢ã«ã®ãã³ã¢ããé¡ã¯ãäžèšäžè¬åŒïŒïŒ
ã§ç€ºãããã äžèšäžè¬åŒïŒïŒäžã§ãã¯ã
âã¢ã«ã®ãã³ã¢ããé¡åã³è¬å€ãšããŠèš±å®¹ãã
åŸããã®å¡©ã«é¢ãããæŽã«è©³ããã¯ãåªããæã
ãã³ãã³äœçšãæãããã€ãæ¯æ§ã®å°ãªãN2â
ã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢ããé¡å
ã³è¬å€ãšããŠèš±å®¹ããåŸããã®å¡©ã«é¢ããã åŸæ¥ãããè¡æ çã®åªããæ²»çè¬ãåŸãããšã
ãå€ãã®è©Šã¿ããªãããŠãããããã®ã²ãšã€ãšã
ãŠãN2âïŒïœâããªã«ã¹ã«ããã«ïŒââã¢ã«
ã®ãã³ãšã¹ãã«é¡ãè¡æ ã溶解ããããšã¯ãç¥ã
ããŠããïŒç±³åœç¹èš±3622615ïŒã ãŸããæ¬çºæè çã¯ãæ¢ã«ãããçš®ã®N2âã¢
ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢ããé¡ãã
ãšãã°N2âãã³ã·ã«ââã¢ã«ã®ãã³ãšã¹ãã«
åã¯ã¢ããé¡ãéžææ§ã®é«ãæããã³ãã³äœçšã
æããè¡æ çã®æ²»çè¬ãšããŠæçšãªååç©ã§ãã
ããšãèŠãåºããŠãããããããããäœæ¯æ§ã§ã
éžææ§ã®é«ãæããã³ãã³å€ã®éçºãæãŸããŠã
ãã æ¬çºæè çã¯ãN2âã¢ãªãŒã«ã¹ã«ããã«â
âã¢ã«ã®ãã³ã¢ããé¡ã«å å«ãããïŒâãN2â
ïŒïŒâã¢ã«ãã«âïŒïŒïŒïŒïŒïŒïŒâããã©ããã
âïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ã
âïŒâãããªãžã³ã«ã«ãã³é žé¡åã³è¬å€ãšããŠèš±
容ããåŸããã®å¡©ããåŸæ¥å ¬ç¥ã®ååç©ã«æ¯ãã
é«ãæããã³ãã³äœçšãæãããšãšãã«ãäœæ¯æ§
ã§ããããšãèŠãåºããã æ¬çºæååç©ã§ããN2âã¢ãªãŒã«ã¹ã«ããã«
ââã¢ã«ã®ãã³ã¢ããé¡ã¯ãäžèšäžè¬åŒïŒïŒ
ã§ç€ºãããã äžèšäžè¬åŒïŒïŒäžã§ãã¯ã
ãåŒãã瀺ããR1ã¯ãæ°ŽçŽ ååãå
ã¯ãC1ãC5ïŒå¥œãŸããã¯C1ãC3ïŒã®ã¢ã«ãã«åºã
瀺ãããŸããArã¯ãïŒäœãã¡ãã«åºåã¯ãšãã«
åºã§çœ®æãããïŒïŒïŒïŒïŒïŒïŒâããã©ãããâ
ïŒâãããªã«åºã瀺ããïŒ æ¬çºæã®ä»£è¡šçååç©ã¯ä»¥äžã®éãã§ããã ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«
ãã³é ž ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâãšãã«âïŒâãããªãžã³ã«ã«
ãã³é ž ïŒâãN2âïŒïŒâãšãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«
ãã³é ž ïŒâãN2âïŒïŒâãšãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâãšãã«âïŒâãããªãžã³ã«ã«
ãã³é ž äžèšååç©ã®è¬å€ãšããŠèš±å®¹ããåŸãå¡©ããæ¬
çºæã®ç¯å²ã«å«ãŸããã ãªããæ¬çºæååç©ã®ãã¡ã§ç¹ã«å¥œãŸãããã®
ã¯ãR1ãã¢ã«ãã«åºã§ããååç©ã§ããã æ¬çºæååç©ã§ããN2âã¢ãªãŒã«ã¹ã«ããã«
ââã¢ã«ã®ãã³ã¢ããé¡ã®è£œé æ³ã¯ãåºçºåæ
åã³ïŒåã¯è£œé äžäžéäœã«ãã€ãŠçš®ã èãããã
ãã以äžã«ããã®å¥œãŸãã補é æ³ã«ã€ããŠããã®
åå¿çµè·¯ãæŠèª¬ããã äžèšåŒäžã«ãããŠãArïŒR1ã¯ãæ¢ã«å®çŸ©ãã
ãŠããéãã§ãããã¯ãããã²ã³ååã瀺ãã
ã¯ããã³ãžã«ãªãã·ã«ã«ããã«åºãtertâã
ããã·ã«ã«ããã«åºçã®Î±âã¢ããåºã®ä¿è·åºã
瀺ããRâ²ãšRâ³ã¯ãããã²ã³ååãŸãã¯ãããåºã
ãã·ã«åºãããªãã«åºããªãã·ã«ã«ããã«åºçã®
ã°ã¢ããžãåºã®ä¿è·åºã§ãããRâ²ïŒRâ³ã®ãã¡å°
ãªããšãïŒã€ã¯ãã°ã¢ããžãåºã®ä¿è·åºã§ããã R2ã¯æ°ŽçŽ ååãæãã¯ãã¡ãã«åºããšãã«åº
çéåžžC1ãC10ã®äœçŽã¢ã«ãã«åºãæãã¯ããã³
ãžã«åºãããšããã«åºçéåžžC7ãC15ã®ã¢ã©ã«ã
ã«åºã§ãããã¯ãïŒäœãã¡ãã«åºåã¯ãšãã«åº
ã§çœ®æãããïŒâãããªã«åºã§ããã N2âã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢
ããïŒïŒã¯ãNGâ眮æâN2âãããªã³ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããïŒïŒãæ°ŽçŽ åå解
ããŠãNGâ眮æåºåã³R2ãã¢ã©ã«ãã«åºã®æã«
ã¯ãã®ã¢ã©ã«ãã«åºãé€å»ããåæã«ããããªã«
åºã®éšåãéå ããŠå¯Ÿå¿ããïŒïŒïŒïŒïŒïŒïŒâã
ãã©ããããããªã«åºãšããããšã«ããåŸãã
ãããŸããR2ãã¢ã«ãã«åºã®å Žåã«ã¯ãæŽã«ã
ããªãžã³ç°ã®ïŒäœã®ãšã¹ãã«åºãå æ°Žå解ãããš
åŸãããã ã°ã¢ããžãåºã®ä¿è·åºã§ãããããåºããã³ãž
ã«ãªãã·ã«ã«ããã«åºãïœâããããã³ãžã«ãªã
ã·ã«ã«ããã«åºçã®ãªãã·ã«ã«ããã«åºã®é€å»
ã¯ããšã¹ãã«åºã®ã¢ã«ã³ãŒã«ã®éšåã§ããã¢ã©ã«
ãã«åºã®é€å»ãšåæ§ãæ°ŽçŽ åå解ã«ãã容æã«ãª
ãããã æ°ŽçŽ åå解åã³éå ã¯ãå ±ã«ãäžæŽ»æ§æº¶åªäžã
æ°ŽçŽ æŽ»æ§è§Šåªã®ååšäžãïŒâã200â奜ãŸããã¯ã
30âã150âã®æ°ŽçŽ é°å²æ°äžã§è¡ãªããããäžèš
ã®äžæŽ»æ§æº¶åªãšããŠã¯ãã¡ã¿ããŒã«ããšã¿ããŒã«
çã®ã¢ã«ã³ãŒã«é¡ããããã¯ãããã©ããããã©
ã³ããžãªããµã³çã®ãšãŒãã«é¡ãæããããããŸ
ããæ°ŽçŽ æŽ»æ§å觊åªãšããŠã¯ãã©ããŒããã±ã«ã
ã³ãã«ãããŸãã¯ããã©ãžãŠã ãçœéãã«ãããŠ
ã ãããžãŠã çã®è²Žéå±è§Šåªãæãããã奜ãŸã
ãã¯ã貎éå±è§Šåªã䜿çšããããåå¿æéã¯ã觊
åªãæ°ŽçŽ å§ãåå¿æž©åºŠã«ããç°ãªãããäžè¬ã«ã
30åãã120æéã®ç¯å²ããéžã°ãããæ°ŽçŽ å§ã¯ã
äžè¬ã«ãïŒã200KgïŒcm2ã奜ãŸããã¯ãïŒã100
KgïŒcm2ã®ç¯å²ããéžã°ããã æ°ŽçŽ åå解åã³éå ã¯ãååŠéè«çã«å®å šã«æ°Ž
çŽ ãåžåããããŸã§ç¶ããå¿ èŠãããã é ¢é žãããããªã³é žçã®ææ©é žããããã¯ãå¡©
é žçã®ç¡æ©é žã®æ·»å ã¯ãæ°ŽçŽ åå解åã³éå åå¿
ãä¿é²ãããŸããé ¢é žçã®ææ©é žã¯ãåç¬ã§æº¶åª
ãšããŠçšããããšãã§ããã å ã«è¿°ã¹ãå æ°Žå解ã¯ããã€è¡ãªã€ãŠãããã
ããªãã¡ãæ°ŽçŽ åå解åã³éå ã®ååŸãããã¯ã
ã®åå¿äžã®ãã€ã§ããããR2ãã¢ã«ãã«åºãã
ãã¯ã¢ã©ã«ãã«åºã®å Žåã®ãšã¹ãã«åºã®å æ°Žå解
ã¯ãç¡æ©é žïŒå¡©é žãç¡«é žçïŒã®ãããªé žãããã
ã¯ãç¡æ©å¡©åºïŒæ°Žé žåãããªãŠã ãæ°Žé žåã«ãªãŠ
ã ãæ°Žé žåããªãŠã ãçé žã«ãªãŠã çïŒã®ãããª
å¡©åºãçšããéåžžã®æ¹æ³ã§è¡ãªãããããã ãã
ããã§R2ãã¢ã©ã«ãã«åºã®å Žåã¯ãæ°ŽçŽ åå解
åã³éå ã®åã«è¡ãªãããå æ°Žå解ã®ã¿ãæãã ã¢ã«ã«ãªã«ããå æ°Žå解ã¯ãéåžžãæ°ŽäžãŸã
ã¯ãæ°Žãå«ãäžæŽ»æ§ææ©æº¶åªïŒäŸãã°ãã¢ã«ã³ãŒ
ã«é¡ãããã©ããããã©ã³ããžãªããµã³ïŒäžã20
âã150âã®æž©åºŠã§è¡ãªããããåå¿æéã¯ãå
å¿æ¡ä»¶ã«ããç°ãªãããéåžžïŒåã20æéã®ç¯å²
ããéžã°ããã é žã«ããå æ°Žå解ã¯ãæ°ŽäžãŸãã¯ãæ°Žãå«ãäž
掻æ§ææ©æº¶åªïŒäŸãã°ãã¢ã«ã³ãŒã«é¡ãããã©ã
ãããã©ã³ããžãªããµã³ïŒäžã20âã150âã®æž©
床ã§ã30åã50æéåå¿ãããããšã«ããè¡ãªã
ããã ïŒâïŒNGâ眮æâN2âãããªã³ã¹ã«ããã«â
âã¢ã«ã®ãã«ïŒâïŒâãããªãžã³ã«ã«ãã³é žã
ããã¯ãïŒâïŒNGâ眮æâN2âãããªã³ã¹ã«ã
ãã«ââã¢ã«ã®ãã«ïŒâïŒâãããªãžã³ã«ã«ã
ãã·ã©ãŒãïŒïŒã¯ãNGâ眮æâN2â眮æâ
âã¢ã«ã®ãã³ïŒïŒïŒäžè¬ã«ãNGâ眮æåºã¯ãã
ããåºãããã¯ã¢ã·ã«åºã§ãããN2â眮æåºã¯ã
ãã³ãžã«ãªãã·ã«ã«ããã«åºãtertâãããã·ã«
ã«ããã«åºçã®ã¢ããåºã®ä¿è·åºã§ãããïŒãŸã
ã¯ããã®åå¿æ§èªå°äœïŒé žããã²ã³åç©ãé žã¢ãž
ãã掻æ§ãšã¹ãã«ãæ··åé žç¡æ°Žç©çïŒãšã察å¿ã
ããããªãžã³ã«ã«ãã³é žãããã¯ãã®ãšã¹ãã«
ïŒïŒãŸãã¯ããã®åå¿æ§èªå°äœïŒã¢ãã·ãªã«èª
å°äœããžã·ãªã«èªå°äœçïŒããå¿ èŠãªãã°ãã«ã«
ããžã€ããã®ãããªçž®åå€ã®ååšäžã§çž®åããã
çæããNGâ眮æâN2â眮æââã¢ã«ã®ãã³
ã¢ããïŒïŒ¶ïŒãæ¥è§Šæ°ŽçŽ åå解ãŸãã¯é žå解ã
ãŠãéžæçã«N2â眮æåºã®ã¿ãé€å»ããããã
ãŠåŸãããNGâ眮æââã¢ã«ã®ãã³ã¢ãã
ïŒïŒãããããªã³ã¹ã«ããã«ãã©ã€ãïŒïŒã奜
ãŸããã¯ããããªã³ã¹ã«ããã«ã¯ããªããšãå¡©åº
ã®ååšäžã溶åªäžã§çž®åãããããšã«ãã補é ã
ãããšãã§ããã æŽã«ãŸããN2âã¢ãªãŒã«ã¹ã«ããã«ââã¢
ã«ã®ãã³ã¢ããïŒïŒã¯ãN2âãããªã³ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããïŒïŒžïŒã®ãããªã«åº
ã®éšåãéå ããŠã察å¿ããïŒïŒïŒïŒïŒïŒïŒâã
ãã©ããããããªã«åºã«ããããšã«ãã€ãŠãã補
é ããããšãã§ããããã®åå¿çµè·¯ã以äžã«ç€º
ãã äžèšåŒäžã«ãããŠãR1ïŒR2ïŒïŒ±ïŒAråã³ïŒž
ã¯ãæ¢ã«å®çŸ©ãããŠããéãã§ããã N2âã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢
ããïŒïŒã¯ãN2âãããªã³ã¹ã«ããã«ââ
ã¢ã«ã®ãã³ã¢ããïŒïŒžïŒã®ãããªã«åºã®éšåãé
å ããåæã«ãR2ãã¢ã©ã«ãã«åºã®å Žåã«ã¯æ°Ž
çŽ åå解ã«ããã¢ã©ã«ãã«åºãé€å»ããR2ãã¢
ã«ãã«åºã®å Žåã«ã¯ã¢ã«ãã«ãšã¹ãã«ãå æ°Žå解
ããããšã«ããåŸãããã éå ãšæ°ŽçŽ åå解ãè¡ãéã®åå¿æ¡ä»¶ã¯ãïŒâ
ïŒNGâ眮æâN2âãããªã³ã¹ã«ããã«ââã¢
ã«ã®ãã«ïŒâïŒâãããªãžã³ã«ã«ãã³é žé¡ããã
ã¯ãããã®ãšã¹ãã«é¡ïŒïŒã®éå åã³æ°ŽçŽ åå
解ã«ãããŠè¿°ã¹ãæ¡ä»¶ãšãã»ãŒåãã§ããã N2âãããªã³ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢
ããïŒïŒžïŒã¯ãN2âãããªã³ã¹ã«ããã«ââ
ã¢ã«ã®ãã³ïŒïŒãŸãã¯ããã®åå¿æ§èªå°äœãäŸ
ãã°ãé žããã²ã³åç©ãé žã¢ãžãã掻æ§ãšã¹ãã«
ïŒïœâãããããšãã«ãšã¹ãã«çïŒãæ··åé žç¡æ°Žç©
çãšã察å¿ãããããªãžã³ã«ã«ãã³é žãããã¯ã
ã®ãšã¹ãã«ïŒïŒãŸãã¯ããã®åå¿æ§èªå°äœãäŸ
ãã°ãã¢ãã·ãªã«èªå°äœããžã·ãªã«èªå°äœçãã
å¿ èŠãªãã°ã«ã«ããžã€ããïŒäŸãã°ãïŒïŒïŒâãž
ã·ã¯ãããã·ã«ã«ã«ããžã€ããïŒã®ãããªçž®åå€
ã®ååšäžã§çž®åããããšã«ããåŸãããã N2âãããªã³ã¹ã«ããã«ââã¢ã«ã®ãã³
ïŒïŒã®åå¿æ§èªå°äœã¯ããããã補é ãããæ
ã®æº¶æ¶²ã®åœ¢ã§äœ¿çšãããšããã䟿å©ã§å®çšçã§ã
ãããšãå€ããçž®åãè¡ãéã®çš®ã ã®æ¡ä»¶ã¯ãåœ
æ¥è ã«ããç¥ãããŠããã N2âãããªã³ã¹ã«ããã«ââã¢ã«ã®ãã³
ïŒïŒã¯ãâã¢ã«ã®ãã³ïŒïŒããã»ãŒåœéã¢
ã«ã®ãããªã³ã¹ã«ããã«ãã©ã€ãïŒïŒã奜ãŸã
ãã¯ããããªã³ã¹ã«ããã«ã¯ããªããšãå¡©åºã®å
åšäžã溶åªäžã§çž®åãããããšã«ããåŸãããã ãã®ããã«ããŠåŸãããN2âã¢ãªãŒã«ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããé¡ïŒïŒã¯ãéåžžã®
æ¹æ³ã«ããåé¢ã粟補ãããäŸãã°ã觊åªãå»
åŸã溶åªãé€å»ããæ©ç ããããã¯ããžãšãã«ãš
ãŒãã«ãŒããã©ããããã©ã³ããžãšãã«ãšãŒãã«
ãŒã¡ã¿ããŒã«ãæ°Žâã¡ã¿ããŒã«çã®æº¶åªããã®å
çµæ¶ããããã¯ãã·ãªã«ã²ã«ãããã¯ã¢ã«ããã
çšããã¯ãããã°ã©ãã€ãŒã«ãã粟補ããã æ¬çºæååç©ã§ããN2âã¢ãªãŒã«ã¹ã«ããã«
ââã¢ã«ã®ãã³ã¢ããé¡ïŒïŒã¯ãçš®ã ã®ç¡æ©
é žãããã¯ææ©é žãšé žä»å å¡©ãäœãããŸãã皮皮
ã®ç¡æ©å¡©åºãããã¯ææ©å¡©åºãšãå¡©ãäœãã äžè¿°ã®åå¿ã§åŸãããN2âã¢ãªãŒã«ã¹ã«ãã
ã«ââã¢ã«ã®ãã³ã¢ããïŒïŒã¯ãéé¢ã®åœ¢æ
ãŸãã¯å¡©ã®åœ¢æ ã§åé¢ããåŸãããŸããéé¢ã®å¡©
é¡ãææã®é žãšåå¿ãããããšã«ãããN2âã¢
ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢ããïŒïŒ
ã®è¬å€ãšããŠèš±å®¹ãåŸãé žä»å å¡©ãåŸãããšãã§
ãããäžèšã®é žãšããŠã¯ãå¡©åæ°ŽçŽ é žãèåæ°ŽçŽ
é žããšãŠåæ°ŽçŽ é žãç¡é žãç¡«é žããªã³é žãé ¢é žã
ã¯ãšã³é žããã¬ã€ã³é žãã³ãã¯é žãä¹³é žãé ç³
é žãã°ã«ã³ã³é žãå®æ¯éŠé žãã¡ã¿ã³ã¹ã«ãã³é žã
ãšã¿ã³ã¹ã«ãã³é žããã³ãŒã³ã¹ã«ãã³é žãïœâã
ã«ãšã³ã¹ã«ãã³é žçãæãããããæ¬çºæã®åå
ç©ã¯ãéé¢ã®ã«ã«ããã·ã«åºãæããã®ã§ææã®
å¡©åºãšåå¿ãããããšã«ãããåæ§ã«ååç©
ïŒïŒã®è¬å€ãšããŠèš±å®¹ããåŸãå¡©ãåŸãããšã
ã§ããããã®ãããªå¡©åºãšããŠã¯ãæ°Žé žåãããª
ãŠã ãæ°Žé žåã«ãªãŠã ãæ°Žé žåã¢ã³ã¢ããŠã ãã
ãªãšãã«ã¢ãã³ãããã«ã€ã³ããžãã³ãžã«ã¢ã
ã³ãïŒâãšããšããã³ãïŒNâ²âãžãã³ãžã«ãš
ãã¬ã³ãžã¢ãã³ãâãšãã«ãããªãžã³çãæã
ãããã ãªãããããã®å¡©ãé žãããã¯å¡©åºã§åŠçãã
ã°ãéé¢ã®ã¢ãããåçããããšãã§ããã æ¢è¿°ã®éããæ¬çºæã®N2âã¢ãªãŒã«ã¹ã«ãã
ã«ââã¢ã«ã®ãã³ã¢ããé¡åã³ãã®å¡©ã¯ãåºä¹³
åç©äœå ã®ããã³ãã³ã«å¯ŸããŠç¹ç°æ§ã®é«ãé»å®³
å¹æãæãããã€ãã»ãšãã©æ¯æ§ããªãããšã
ããè¡äžã®ããã³ãã³ã枬å®ãã蚺æè¬ãåã³ïŒ
åã¯ãè¡æ çã®æ²»çãããã¯äºé²ã«æçšã§ããã æŽã«ãæ¬çºæã®ååç©ã¯ãè¡å°æ¿åéé»æ¢å€ãš
ããŠãæçšã§ããã æ¬çºæååç©ã®N2âã¢ãªãŒã«ã¹ã«ããã«â
âã¢ã«ã®ãã³ã¢ããé¡ã®æããã³ãã³äœçšããã¢
ã€ããªããŒã²ã³ãååºæéã枬å®ããããšã«ã
ããæ¢ç¥ã®æããã³ãã³å€ã§ããN2âïŒïœâã
ãªã«ã¹ã«ããã«ïŒââã¢ã«ã®ãã³ã¡ãã«ãšã¹ã
ã«ïŒä»¥äžTAMEãšç¥ç§°ããïŒãšæ¯èŒããã ãã€ããªããŒã²ã³ååºæéã®æž¬å®ã¯ã次ã®ãã
ã«ããŠè¡ã€ãã çãã€ããªããŒã²ã³ïŒã³ãŒã³ ãã©ã¯ã·ãšã³ïŒ©
ïŒCohn Fraction ïŒãã¢ãŒããŒïŒArmourïŒç€Ÿ
補ïŒ150mgã40mlã®ãã¬ãŒã ãµã©ã€ã³ ããã
ã¢ãŒïŒBorate Saline BufferïŒPH7.4ïŒïŒã«æº¶è§£ã
ãŠåŸããããã€ããªããŒã²ã³æº¶æ¶²0.8mlãã0.1ml
ã®ãã¬ãŒã ãµã©ã€ã³ ãããã¢ãŒïŒå¯Ÿç §è©Šæã
PH7.4ïŒããããã¯ãè©Šæ溶液ãšæ°·å·äžã§æ··åãã
æŽã«ã5unitsïŒmlã®ããã³ãã³ïŒæç°è£œè¬(æ ª)補詊
è¬ïŒæº¶æ¶²0.1mlãæ°·å·äžã§æ·»å ãããããæ··åã
ãåŸãçŽã¡ã«ãã®åå¿æ··åç©ã25âã®æ枩槜ã«ç§»
ããæ枩槜ã«å ¥ããç¬éã«ã¹ããããŠãªãããå§
åããããã€ããªã³ç³»ãèªããæãŸã§ã®æéã枬
å®ãããè©Šæç¡æ·»å ã®å ŽåïŒå¯Ÿç §å®éšïŒã®ååºæ
éã¯50â55ç§ã§ãã€ãã å®éšçµæãè¡šâïŒã«ç€ºããè¡šâïŒã§ãååºæé
ãïŒåã«å»¶é·ããæ¿åºŠããšã¯ãå¯Ÿç §å®éšã§ã®ååº
æé50ã55ç§ãååºæé100ã110ç§ã«å»¶é·ããã®
ã«å¿ èŠãªæå¹æåã®æ¿åºŠãè¡šããã TAMEã«ã€ããŠã¯ããã®ååºæéãïŒåã«å»¶
é·ããæ¿åºŠã¯1100ÎŒMã§ãã€ãã ãªãäžèšè¡šâïŒã«ãããŠN2âã¢ãªãŒã«ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããé¡ïŒïŒã¯äžè¬åŒ
ïŒïŒäžã®ïŒ²ïŒArããã³ä»å ç©ãç¹å®ããããšã«
ããè¡šããã æ¬çºæã®N2âã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«
ã®ãã³ã¢ããé¡ïŒïŒã®æº¶æ¶²ãåç©ã«éèå æäž
ããå Žåã埪ç°è¡äžã®é«ãæããã³ãã³äœçšãïŒ
ãïŒæéä¿æãããæ¬çºæã®æããã³ãã³å€ã®åŸª
ç°è¡äžã®æ¶å€±åæžæã¯ã»ãŒ60åã§ãã€ããå®éšå
ç©ïŒã©ãããå ãç¬ããã³ãã³ãã³ãžãŒïŒã®çç
ç¶æ ã¯è¯å¥œã«ä¿ãããã å®éšåç©ã«ããã³ãã³ãé£ç¶æ³šå ¥ããããšã«ã
ã€ãŠèµ·ããã€ããªããŒã²ã³ã®æžå°ã¯ãæ¬çºæã®é»
害å€ãåææ³šå ¥ããããšã«ããæå¶ãããã æ¬çºæååç©ã®ããŠã¹ïŒéæ§ã20ïœïŒã«å¯Ÿãã
éèå æäžã«ããæ¥æ§æ¯æ§å€ïŒLD50ïŒã¯çŽ150ã
1600mgïŒKgäœéã§ããã æ¬çºæååç©ã®ä»£è¡šçãªLD50å€ãäžèšè¡šã«ç€º
ãã
瀺ãããŸããArã¯ãïŒäœãã¡ãã«åºåã¯ãšãã«
åºã§çœ®æãããïŒïŒïŒïŒïŒïŒïŒâããã©ãããâ
ïŒâãããªã«åºã瀺ããïŒ æ¬çºæã®ä»£è¡šçååç©ã¯ä»¥äžã®éãã§ããã ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«
ãã³é ž ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâãšãã«âïŒâãããªãžã³ã«ã«
ãã³é ž ïŒâãN2âïŒïŒâãšãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«
ãã³é ž ïŒâãN2âïŒïŒâãšãã«âïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒââ
ã¢ã«ã®ãã«ãâïŒâãšãã«âïŒâãããªãžã³ã«ã«
ãã³é ž äžèšååç©ã®è¬å€ãšããŠèš±å®¹ããåŸãå¡©ããæ¬
çºæã®ç¯å²ã«å«ãŸããã ãªããæ¬çºæååç©ã®ãã¡ã§ç¹ã«å¥œãŸãããã®
ã¯ãR1ãã¢ã«ãã«åºã§ããååç©ã§ããã æ¬çºæååç©ã§ããN2âã¢ãªãŒã«ã¹ã«ããã«
ââã¢ã«ã®ãã³ã¢ããé¡ã®è£œé æ³ã¯ãåºçºåæ
åã³ïŒåã¯è£œé äžäžéäœã«ãã€ãŠçš®ã èãããã
ãã以äžã«ããã®å¥œãŸãã補é æ³ã«ã€ããŠããã®
åå¿çµè·¯ãæŠèª¬ããã äžèšåŒäžã«ãããŠãArïŒR1ã¯ãæ¢ã«å®çŸ©ãã
ãŠããéãã§ãããã¯ãããã²ã³ååã瀺ãã
ã¯ããã³ãžã«ãªãã·ã«ã«ããã«åºãtertâã
ããã·ã«ã«ããã«åºçã®Î±âã¢ããåºã®ä¿è·åºã
瀺ããRâ²ãšRâ³ã¯ãããã²ã³ååãŸãã¯ãããåºã
ãã·ã«åºãããªãã«åºããªãã·ã«ã«ããã«åºçã®
ã°ã¢ããžãåºã®ä¿è·åºã§ãããRâ²ïŒRâ³ã®ãã¡å°
ãªããšãïŒã€ã¯ãã°ã¢ããžãåºã®ä¿è·åºã§ããã R2ã¯æ°ŽçŽ ååãæãã¯ãã¡ãã«åºããšãã«åº
çéåžžC1ãC10ã®äœçŽã¢ã«ãã«åºãæãã¯ããã³
ãžã«åºãããšããã«åºçéåžžC7ãC15ã®ã¢ã©ã«ã
ã«åºã§ãããã¯ãïŒäœãã¡ãã«åºåã¯ãšãã«åº
ã§çœ®æãããïŒâãããªã«åºã§ããã N2âã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢
ããïŒïŒã¯ãNGâ眮æâN2âãããªã³ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããïŒïŒãæ°ŽçŽ åå解
ããŠãNGâ眮æåºåã³R2ãã¢ã©ã«ãã«åºã®æã«
ã¯ãã®ã¢ã©ã«ãã«åºãé€å»ããåæã«ããããªã«
åºã®éšåãéå ããŠå¯Ÿå¿ããïŒïŒïŒïŒïŒïŒïŒâã
ãã©ããããããªã«åºãšããããšã«ããåŸãã
ãããŸããR2ãã¢ã«ãã«åºã®å Žåã«ã¯ãæŽã«ã
ããªãžã³ç°ã®ïŒäœã®ãšã¹ãã«åºãå æ°Žå解ãããš
åŸãããã ã°ã¢ããžãåºã®ä¿è·åºã§ãããããåºããã³ãž
ã«ãªãã·ã«ã«ããã«åºãïœâããããã³ãžã«ãªã
ã·ã«ã«ããã«åºçã®ãªãã·ã«ã«ããã«åºã®é€å»
ã¯ããšã¹ãã«åºã®ã¢ã«ã³ãŒã«ã®éšåã§ããã¢ã©ã«
ãã«åºã®é€å»ãšåæ§ãæ°ŽçŽ åå解ã«ãã容æã«ãª
ãããã æ°ŽçŽ åå解åã³éå ã¯ãå ±ã«ãäžæŽ»æ§æº¶åªäžã
æ°ŽçŽ æŽ»æ§è§Šåªã®ååšäžãïŒâã200â奜ãŸããã¯ã
30âã150âã®æ°ŽçŽ é°å²æ°äžã§è¡ãªããããäžèš
ã®äžæŽ»æ§æº¶åªãšããŠã¯ãã¡ã¿ããŒã«ããšã¿ããŒã«
çã®ã¢ã«ã³ãŒã«é¡ããããã¯ãããã©ããããã©
ã³ããžãªããµã³çã®ãšãŒãã«é¡ãæããããããŸ
ããæ°ŽçŽ æŽ»æ§å觊åªãšããŠã¯ãã©ããŒããã±ã«ã
ã³ãã«ãããŸãã¯ããã©ãžãŠã ãçœéãã«ãããŠ
ã ãããžãŠã çã®è²Žéå±è§Šåªãæãããã奜ãŸã
ãã¯ã貎éå±è§Šåªã䜿çšããããåå¿æéã¯ã觊
åªãæ°ŽçŽ å§ãåå¿æž©åºŠã«ããç°ãªãããäžè¬ã«ã
30åãã120æéã®ç¯å²ããéžã°ãããæ°ŽçŽ å§ã¯ã
äžè¬ã«ãïŒã200KgïŒcm2ã奜ãŸããã¯ãïŒã100
KgïŒcm2ã®ç¯å²ããéžã°ããã æ°ŽçŽ åå解åã³éå ã¯ãååŠéè«çã«å®å šã«æ°Ž
çŽ ãåžåããããŸã§ç¶ããå¿ èŠãããã é ¢é žãããããªã³é žçã®ææ©é žããããã¯ãå¡©
é žçã®ç¡æ©é žã®æ·»å ã¯ãæ°ŽçŽ åå解åã³éå åå¿
ãä¿é²ãããŸããé ¢é žçã®ææ©é žã¯ãåç¬ã§æº¶åª
ãšããŠçšããããšãã§ããã å ã«è¿°ã¹ãå æ°Žå解ã¯ããã€è¡ãªã€ãŠãããã
ããªãã¡ãæ°ŽçŽ åå解åã³éå ã®ååŸãããã¯ã
ã®åå¿äžã®ãã€ã§ããããR2ãã¢ã«ãã«åºãã
ãã¯ã¢ã©ã«ãã«åºã®å Žåã®ãšã¹ãã«åºã®å æ°Žå解
ã¯ãç¡æ©é žïŒå¡©é žãç¡«é žçïŒã®ãããªé žãããã
ã¯ãç¡æ©å¡©åºïŒæ°Žé žåãããªãŠã ãæ°Žé žåã«ãªãŠ
ã ãæ°Žé žåããªãŠã ãçé žã«ãªãŠã çïŒã®ãããª
å¡©åºãçšããéåžžã®æ¹æ³ã§è¡ãªãããããã ãã
ããã§R2ãã¢ã©ã«ãã«åºã®å Žåã¯ãæ°ŽçŽ åå解
åã³éå ã®åã«è¡ãªãããå æ°Žå解ã®ã¿ãæãã ã¢ã«ã«ãªã«ããå æ°Žå解ã¯ãéåžžãæ°ŽäžãŸã
ã¯ãæ°Žãå«ãäžæŽ»æ§ææ©æº¶åªïŒäŸãã°ãã¢ã«ã³ãŒ
ã«é¡ãããã©ããããã©ã³ããžãªããµã³ïŒäžã20
âã150âã®æž©åºŠã§è¡ãªããããåå¿æéã¯ãå
å¿æ¡ä»¶ã«ããç°ãªãããéåžžïŒåã20æéã®ç¯å²
ããéžã°ããã é žã«ããå æ°Žå解ã¯ãæ°ŽäžãŸãã¯ãæ°Žãå«ãäž
掻æ§ææ©æº¶åªïŒäŸãã°ãã¢ã«ã³ãŒã«é¡ãããã©ã
ãããã©ã³ããžãªããµã³ïŒäžã20âã150âã®æž©
床ã§ã30åã50æéåå¿ãããããšã«ããè¡ãªã
ããã ïŒâïŒNGâ眮æâN2âãããªã³ã¹ã«ããã«â
âã¢ã«ã®ãã«ïŒâïŒâãããªãžã³ã«ã«ãã³é žã
ããã¯ãïŒâïŒNGâ眮æâN2âãããªã³ã¹ã«ã
ãã«ââã¢ã«ã®ãã«ïŒâïŒâãããªãžã³ã«ã«ã
ãã·ã©ãŒãïŒïŒã¯ãNGâ眮æâN2â眮æâ
âã¢ã«ã®ãã³ïŒïŒïŒäžè¬ã«ãNGâ眮æåºã¯ãã
ããåºãããã¯ã¢ã·ã«åºã§ãããN2â眮æåºã¯ã
ãã³ãžã«ãªãã·ã«ã«ããã«åºãtertâãããã·ã«
ã«ããã«åºçã®ã¢ããåºã®ä¿è·åºã§ãããïŒãŸã
ã¯ããã®åå¿æ§èªå°äœïŒé žããã²ã³åç©ãé žã¢ãž
ãã掻æ§ãšã¹ãã«ãæ··åé žç¡æ°Žç©çïŒãšã察å¿ã
ããããªãžã³ã«ã«ãã³é žãããã¯ãã®ãšã¹ãã«
ïŒïŒãŸãã¯ããã®åå¿æ§èªå°äœïŒã¢ãã·ãªã«èª
å°äœããžã·ãªã«èªå°äœçïŒããå¿ èŠãªãã°ãã«ã«
ããžã€ããã®ãããªçž®åå€ã®ååšäžã§çž®åããã
çæããNGâ眮æâN2â眮æââã¢ã«ã®ãã³
ã¢ããïŒïŒ¶ïŒãæ¥è§Šæ°ŽçŽ åå解ãŸãã¯é žå解ã
ãŠãéžæçã«N2â眮æåºã®ã¿ãé€å»ããããã
ãŠåŸãããNGâ眮æââã¢ã«ã®ãã³ã¢ãã
ïŒïŒãããããªã³ã¹ã«ããã«ãã©ã€ãïŒïŒã奜
ãŸããã¯ããããªã³ã¹ã«ããã«ã¯ããªããšãå¡©åº
ã®ååšäžã溶åªäžã§çž®åãããããšã«ãã補é ã
ãããšãã§ããã æŽã«ãŸããN2âã¢ãªãŒã«ã¹ã«ããã«ââã¢
ã«ã®ãã³ã¢ããïŒïŒã¯ãN2âãããªã³ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããïŒïŒžïŒã®ãããªã«åº
ã®éšåãéå ããŠã察å¿ããïŒïŒïŒïŒïŒïŒïŒâã
ãã©ããããããªã«åºã«ããããšã«ãã€ãŠãã補
é ããããšãã§ããããã®åå¿çµè·¯ã以äžã«ç€º
ãã äžèšåŒäžã«ãããŠãR1ïŒR2ïŒïŒ±ïŒAråã³ïŒž
ã¯ãæ¢ã«å®çŸ©ãããŠããéãã§ããã N2âã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢
ããïŒïŒã¯ãN2âãããªã³ã¹ã«ããã«ââ
ã¢ã«ã®ãã³ã¢ããïŒïŒžïŒã®ãããªã«åºã®éšåãé
å ããåæã«ãR2ãã¢ã©ã«ãã«åºã®å Žåã«ã¯æ°Ž
çŽ åå解ã«ããã¢ã©ã«ãã«åºãé€å»ããR2ãã¢
ã«ãã«åºã®å Žåã«ã¯ã¢ã«ãã«ãšã¹ãã«ãå æ°Žå解
ããããšã«ããåŸãããã éå ãšæ°ŽçŽ åå解ãè¡ãéã®åå¿æ¡ä»¶ã¯ãïŒâ
ïŒNGâ眮æâN2âãããªã³ã¹ã«ããã«ââã¢
ã«ã®ãã«ïŒâïŒâãããªãžã³ã«ã«ãã³é žé¡ããã
ã¯ãããã®ãšã¹ãã«é¡ïŒïŒã®éå åã³æ°ŽçŽ åå
解ã«ãããŠè¿°ã¹ãæ¡ä»¶ãšãã»ãŒåãã§ããã N2âãããªã³ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢
ããïŒïŒžïŒã¯ãN2âãããªã³ã¹ã«ããã«ââ
ã¢ã«ã®ãã³ïŒïŒãŸãã¯ããã®åå¿æ§èªå°äœãäŸ
ãã°ãé žããã²ã³åç©ãé žã¢ãžãã掻æ§ãšã¹ãã«
ïŒïœâãããããšãã«ãšã¹ãã«çïŒãæ··åé žç¡æ°Žç©
çãšã察å¿ãããããªãžã³ã«ã«ãã³é žãããã¯ã
ã®ãšã¹ãã«ïŒïŒãŸãã¯ããã®åå¿æ§èªå°äœãäŸ
ãã°ãã¢ãã·ãªã«èªå°äœããžã·ãªã«èªå°äœçãã
å¿ èŠãªãã°ã«ã«ããžã€ããïŒäŸãã°ãïŒïŒïŒâãž
ã·ã¯ãããã·ã«ã«ã«ããžã€ããïŒã®ãããªçž®åå€
ã®ååšäžã§çž®åããããšã«ããåŸãããã N2âãããªã³ã¹ã«ããã«ââã¢ã«ã®ãã³
ïŒïŒã®åå¿æ§èªå°äœã¯ããããã補é ãããæ
ã®æº¶æ¶²ã®åœ¢ã§äœ¿çšãããšããã䟿å©ã§å®çšçã§ã
ãããšãå€ããçž®åãè¡ãéã®çš®ã ã®æ¡ä»¶ã¯ãåœ
æ¥è ã«ããç¥ãããŠããã N2âãããªã³ã¹ã«ããã«ââã¢ã«ã®ãã³
ïŒïŒã¯ãâã¢ã«ã®ãã³ïŒïŒããã»ãŒåœéã¢
ã«ã®ãããªã³ã¹ã«ããã«ãã©ã€ãïŒïŒã奜ãŸã
ãã¯ããããªã³ã¹ã«ããã«ã¯ããªããšãå¡©åºã®å
åšäžã溶åªäžã§çž®åãããããšã«ããåŸãããã ãã®ããã«ããŠåŸãããN2âã¢ãªãŒã«ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããé¡ïŒïŒã¯ãéåžžã®
æ¹æ³ã«ããåé¢ã粟補ãããäŸãã°ã觊åªãå»
åŸã溶åªãé€å»ããæ©ç ããããã¯ããžãšãã«ãš
ãŒãã«ãŒããã©ããããã©ã³ããžãšãã«ãšãŒãã«
ãŒã¡ã¿ããŒã«ãæ°Žâã¡ã¿ããŒã«çã®æº¶åªããã®å
çµæ¶ããããã¯ãã·ãªã«ã²ã«ãããã¯ã¢ã«ããã
çšããã¯ãããã°ã©ãã€ãŒã«ãã粟補ããã æ¬çºæååç©ã§ããN2âã¢ãªãŒã«ã¹ã«ããã«
ââã¢ã«ã®ãã³ã¢ããé¡ïŒïŒã¯ãçš®ã ã®ç¡æ©
é žãããã¯ææ©é žãšé žä»å å¡©ãäœãããŸãã皮皮
ã®ç¡æ©å¡©åºãããã¯ææ©å¡©åºãšãå¡©ãäœãã äžè¿°ã®åå¿ã§åŸãããN2âã¢ãªãŒã«ã¹ã«ãã
ã«ââã¢ã«ã®ãã³ã¢ããïŒïŒã¯ãéé¢ã®åœ¢æ
ãŸãã¯å¡©ã®åœ¢æ ã§åé¢ããåŸãããŸããéé¢ã®å¡©
é¡ãææã®é žãšåå¿ãããããšã«ãããN2âã¢
ãªãŒã«ã¹ã«ããã«ââã¢ã«ã®ãã³ã¢ããïŒïŒ
ã®è¬å€ãšããŠèš±å®¹ãåŸãé žä»å å¡©ãåŸãããšãã§
ãããäžèšã®é žãšããŠã¯ãå¡©åæ°ŽçŽ é žãèåæ°ŽçŽ
é žããšãŠåæ°ŽçŽ é žãç¡é žãç¡«é žããªã³é žãé ¢é žã
ã¯ãšã³é žããã¬ã€ã³é žãã³ãã¯é žãä¹³é žãé ç³
é žãã°ã«ã³ã³é žãå®æ¯éŠé žãã¡ã¿ã³ã¹ã«ãã³é žã
ãšã¿ã³ã¹ã«ãã³é žããã³ãŒã³ã¹ã«ãã³é žãïœâã
ã«ãšã³ã¹ã«ãã³é žçãæãããããæ¬çºæã®åå
ç©ã¯ãéé¢ã®ã«ã«ããã·ã«åºãæããã®ã§ææã®
å¡©åºãšåå¿ãããããšã«ãããåæ§ã«ååç©
ïŒïŒã®è¬å€ãšããŠèš±å®¹ããåŸãå¡©ãåŸãããšã
ã§ããããã®ãããªå¡©åºãšããŠã¯ãæ°Žé žåãããª
ãŠã ãæ°Žé žåã«ãªãŠã ãæ°Žé žåã¢ã³ã¢ããŠã ãã
ãªãšãã«ã¢ãã³ãããã«ã€ã³ããžãã³ãžã«ã¢ã
ã³ãïŒâãšããšããã³ãïŒNâ²âãžãã³ãžã«ãš
ãã¬ã³ãžã¢ãã³ãâãšãã«ãããªãžã³çãæã
ãããã ãªãããããã®å¡©ãé žãããã¯å¡©åºã§åŠçãã
ã°ãéé¢ã®ã¢ãããåçããããšãã§ããã æ¢è¿°ã®éããæ¬çºæã®N2âã¢ãªãŒã«ã¹ã«ãã
ã«ââã¢ã«ã®ãã³ã¢ããé¡åã³ãã®å¡©ã¯ãåºä¹³
åç©äœå ã®ããã³ãã³ã«å¯ŸããŠç¹ç°æ§ã®é«ãé»å®³
å¹æãæãããã€ãã»ãšãã©æ¯æ§ããªãããšã
ããè¡äžã®ããã³ãã³ã枬å®ãã蚺æè¬ãåã³ïŒ
åã¯ãè¡æ çã®æ²»çãããã¯äºé²ã«æçšã§ããã æŽã«ãæ¬çºæã®ååç©ã¯ãè¡å°æ¿åéé»æ¢å€ãš
ããŠãæçšã§ããã æ¬çºæååç©ã®N2âã¢ãªãŒã«ã¹ã«ããã«â
âã¢ã«ã®ãã³ã¢ããé¡ã®æããã³ãã³äœçšããã¢
ã€ããªããŒã²ã³ãååºæéã枬å®ããããšã«ã
ããæ¢ç¥ã®æããã³ãã³å€ã§ããN2âïŒïœâã
ãªã«ã¹ã«ããã«ïŒââã¢ã«ã®ãã³ã¡ãã«ãšã¹ã
ã«ïŒä»¥äžTAMEãšç¥ç§°ããïŒãšæ¯èŒããã ãã€ããªããŒã²ã³ååºæéã®æž¬å®ã¯ã次ã®ãã
ã«ããŠè¡ã€ãã çãã€ããªããŒã²ã³ïŒã³ãŒã³ ãã©ã¯ã·ãšã³ïŒ©
ïŒCohn Fraction ïŒãã¢ãŒããŒïŒArmourïŒç€Ÿ
補ïŒ150mgã40mlã®ãã¬ãŒã ãµã©ã€ã³ ããã
ã¢ãŒïŒBorate Saline BufferïŒPH7.4ïŒïŒã«æº¶è§£ã
ãŠåŸããããã€ããªããŒã²ã³æº¶æ¶²0.8mlãã0.1ml
ã®ãã¬ãŒã ãµã©ã€ã³ ãããã¢ãŒïŒå¯Ÿç §è©Šæã
PH7.4ïŒããããã¯ãè©Šæ溶液ãšæ°·å·äžã§æ··åãã
æŽã«ã5unitsïŒmlã®ããã³ãã³ïŒæç°è£œè¬(æ ª)補詊
è¬ïŒæº¶æ¶²0.1mlãæ°·å·äžã§æ·»å ãããããæ··åã
ãåŸãçŽã¡ã«ãã®åå¿æ··åç©ã25âã®æ枩槜ã«ç§»
ããæ枩槜ã«å ¥ããç¬éã«ã¹ããããŠãªãããå§
åããããã€ããªã³ç³»ãèªããæãŸã§ã®æéã枬
å®ãããè©Šæç¡æ·»å ã®å ŽåïŒå¯Ÿç §å®éšïŒã®ååºæ
éã¯50â55ç§ã§ãã€ãã å®éšçµæãè¡šâïŒã«ç€ºããè¡šâïŒã§ãååºæé
ãïŒåã«å»¶é·ããæ¿åºŠããšã¯ãå¯Ÿç §å®éšã§ã®ååº
æé50ã55ç§ãååºæé100ã110ç§ã«å»¶é·ããã®
ã«å¿ èŠãªæå¹æåã®æ¿åºŠãè¡šããã TAMEã«ã€ããŠã¯ããã®ååºæéãïŒåã«å»¶
é·ããæ¿åºŠã¯1100ÎŒMã§ãã€ãã ãªãäžèšè¡šâïŒã«ãããŠN2âã¢ãªãŒã«ã¹ã«ã
ãã«ââã¢ã«ã®ãã³ã¢ããé¡ïŒïŒã¯äžè¬åŒ
ïŒïŒäžã®ïŒ²ïŒArããã³ä»å ç©ãç¹å®ããããšã«
ããè¡šããã æ¬çºæã®N2âã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«
ã®ãã³ã¢ããé¡ïŒïŒã®æº¶æ¶²ãåç©ã«éèå æäž
ããå Žåã埪ç°è¡äžã®é«ãæããã³ãã³äœçšãïŒ
ãïŒæéä¿æãããæ¬çºæã®æããã³ãã³å€ã®åŸª
ç°è¡äžã®æ¶å€±åæžæã¯ã»ãŒ60åã§ãã€ããå®éšå
ç©ïŒã©ãããå ãç¬ããã³ãã³ãã³ãžãŒïŒã®çç
ç¶æ ã¯è¯å¥œã«ä¿ãããã å®éšåç©ã«ããã³ãã³ãé£ç¶æ³šå ¥ããããšã«ã
ã€ãŠèµ·ããã€ããªããŒã²ã³ã®æžå°ã¯ãæ¬çºæã®é»
害å€ãåææ³šå ¥ããããšã«ããæå¶ãããã æ¬çºæååç©ã®ããŠã¹ïŒéæ§ã20ïœïŒã«å¯Ÿãã
éèå æäžã«ããæ¥æ§æ¯æ§å€ïŒLD50ïŒã¯çŽ150ã
1600mgïŒKgäœéã§ããã æ¬çºæååç©ã®ä»£è¡šçãªLD50å€ãäžèšè¡šã«ç€º
ãã
ãè¡šã
ä»æ¹ãN2âãã³ã·ã«ââããã«ââã¢ã«
ã®ãã³ã¢ããåã³N2âãã³ã·ã«ââã¡ãã«â
âããã«ââã¢ã«ã®ãã³ã¢ããã®LD50å€ã¯ã
ããããã10mgïŒKgãïŒmgïŒKgã§ããã æ¬çºæã®æ²»çå€ã¯ãåç¬ãŸãã¯è¬å€çã«å¯èœãª
æ äœãšè€åããŠã人éãå«ãåºä¹³åç©ã«æäžãã
ãããã®çµæã¯ãååç©ã®æº¶è§£åºŠãååŠçæ§è³ªã
æäžçµè·¯ãæäžèšç»çã«ãã€ãŠæ±ºå®ãããã ããšãã°ãååç©ãéçµå£çã«çèå 泚å°ãé
èå 泚å°ãç®äžæ³šå°ã§æäžããå Žåã溶液ãç匵
ã«ããããã«é£å¡©ãããã¯ã°ã«ã³ãŒã¹çã®ä»ã®æº¶
質ãæ·»å ããç¡è溶液ãšããŠäœ¿çšãããããŸãå
åç©ã¯ãã§ãã·ããä¹³ç³ãçœç³çã®é©åœãªè³Šåœ¢å€
ãå«ãé å€ãã«ãã»ã«å€ãŸãã¯é¡ç²å€ã®åœ¢ã§çµå£
æäžãããããŸãååç©ã«ç³ãã³ãŒã³ã·ãããã
éŠæãè²çŽ çãå ããŠè±æ°ŽæåãåºååããŠãã
ãŒããŸãã¯ããŒã³ãžã®ãããªå£äžé ãšããŠäœ¿çšã
ãããŸã溶液ãšããŠçµå£æäžããå Žåã¯çè²å€ã
ãã³éŠæãå ããã æ¬çºæã®æ²»çå€ã®ã人éã«æé©ãªæäžéã¯ãæ
äžæ³ãååç©ã®çš®é¡ãæ£è ã®ç¶æ ã«ãããå»åž«ã«
ãã€ãŠæ±ºå®ãããã çµå£æäžã§éçµå£æåã§åŸãããã®ãšåçã®å¹
æãåŸãã«ã¯å€§éæäžãå¿ èŠã§ããã æ²»çéã¯äžè¬ã«éçµå£æäžã§æå¹æå10ã50
mgïŒKgïŒæ¥ãçµå£æäžã§10ã500mgïŒKgïŒæ¥ã§ã
ãã 次ã«æ¬çºæååç©ã®è£œæ³ãå®æœäŸã«ãŠããã«å ·
äœçã«èª¬æããããæ¬çºæã¯ãã®èŠæšãè¶ ããªã
éãããããã®å®æœäŸã§åæãããååç©ã«éå®
ãããªãã ãªããæ¬çºæã«ã¯ãæ¬çºæã®ååç©ãæå¹æå
ãšããŠå«ãè¬å€ççµæç©ãå«ãŸããããã®ãããª
çµæç©ã¯äžèšãããããªåœ¢æ ã§ãããç¹ã«æ¬çºæ
ã¯åäžæäžåœ¢åŒã®çµæç©ãå«ãã å®æœäŸ ïŒ (A) ãšãã«ïŒâãNGâãããâN2âïŒtertâã
ããã·ã«ã«ããã«ïŒââã¢ã«ã®ãã«ãâïŒâ
ã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒãïŒ NGâãããâN2âïŒtertâãããã·ã«ã«ã
ãã«ïŒââã¢ã«ã®ãã³28.3ïœã也ç¥ããã©ã
ãããã©ã³450mlã«æº¶è§£ãã溶液ãæ¹æããªã
ããããã«ãããªãšãã«ã¢ãã³9.0ïœåã³ã¯ã
ãã®é žã€ãœããã«12.2ïœãé 次添å ããããã®
æäœã¯ã枩床ãâ20âã«ä¿ã¡ãªããè¡ã€ãã10
ååŸãããã«ããšãã«ïŒâã¡ãã«âïŒâãããª
ãžã³ã«ã«ããã·ã©ãŒã15.2ïœãå ããæ··åç©ã
â20âã§10åéæ¹æãã次ãã§å®€æž©ãŸã§å æž©ã
ãã溶åªãçå»ããæ®çç©ã400mlã®é ¢é žãšã
ã«ã«æº¶è§£ãããã®æº¶æ¶²ã200mlã®æ°Žã100mlã®ïŒ
ïŒ çé žæ°ŽçŽ ãããªãŠã 溶液ã100mlã®10ïŒ ã¯ãš
ã³é žæº¶æ¶²ã200mlã®æ°Žã§é 次æŽæµããåŸãç¡æ°Ž
ç¡«é žãããªãŠã ã§ä¹Ÿç¥ããã 溶åªãçå»ãããšãã·ãããç¶ã®ãšãã«ïŒâ
ãNGâãããâN2âïŒtertâãããã·ã«ã«ãã
ã«ïŒââã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâã
ããªãžã³ã«ã«ããã·ã©ãŒã31.5ïœïŒåç75ïŒ ïŒ
ãåŸãããã I.R.ïŒKBrïŒïŒ3300ïŒ1730ïŒ1680cm-1 (B) ãšãã«ïŒâãNGâãããââã¢ã«ã®ãã«ã
âïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒ
ãå¡©é žå¡©ïŒ ãšãã«ïŒâãNGâãããâN2âïŒtertâã
ããã·ã«ã«ããã«ïŒââã¢ã«ã®ãã«ãâïŒâ
ã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒã30ïœ
ãé ¢é žãšãã«50mlã«æº¶è§£ãã溶液ãæ¹æããªã
ãã80mlã®10ïŒ ä¹Ÿç¥å¡©é žâé ¢é žãšãã«ãå ã
ãããã®æäœã¯ã枩床ãïŒâã«ä¿ã€ãŠè¡ã€ãã
ïŒæéåŸããã®æº¶æ¶²ã«200mlã®ä¹Ÿç¥ãšãã«ãšãŒ
ãã«ãå ãããšãç²çš ãªæ²¹ç¶ç©è³ªãæåºããã
ãããéåŸã也ç¥ãšãã«ãšãŒãã«ã§æŽæµãã
ãšãç¡å®åœ¢åºäœã®ãšãã«ïŒâãNGâãããâ
âã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãž
ã³ã«ã«ããã·ã©ãŒãå¡©é žå¡©ãåŸãããã (C) ãšãã«ïŒâãNGâãããâN2âïŒïŒâã¡ã
ã«âïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ã
ã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·
ã©ãŒãïŒ ãšãã«ïŒâïŒNGâãããââã¢ã«ã®ãã«ïŒ
âïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒ
ãå¡©é žå¡©25ïœã200mlã®ã¯ãããã«ã ã«æº¶è§£ã
ã溶液ãæ¹æããªãããããªãšãã«ã¢ãã³18.5
ïœãšïŒâã¡ãã«âïŒâãããªã³ã¹ã«ããã«ã¯ã
ãªã14.7ïœãé 次添å ããããã®æäœã¯ã枩床
ãïŒâã«ä¿ã€ãŠè¡ã€ããåå¿æ··åç©ã宀枩ã§ïŒ
æéæ¹æããåŸã50mlã®æ°Žã§ïŒåæŽæµããã ãã®ã¯ãããã«ã 溶液ãç¡æ°Žç¡«é žãããªãŠã
ã§ä¹Ÿç¥ããåŸã溶åªãçå»ããæ®çç©ãã·ãªã«
ã²ã«ïŒã¯ãããã«ã äžïŒ50ïœã®ã¯ãããã°ã©ã
ã€ãŒã«ããããã¯ãããã«ã ã§æŽæµåŸãïŒïŒ ã¡
ã¿ããŒã«ãå«ãã¯ãããã«ã ã§ã§æº¶åºãããç»
åãèžçºãããšãç¡å®åœ¢åºäœã®ãšãã«ïŒâ
ãNGâãããâN2âïŒïŒâã¡ãã«âïŒâãã
ãªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ãâïŒâã¡
ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒã32.1ïœ
ãåŸãããã I.R.ïŒKBrïŒïŒ3250ïŒ1725ïŒ1640cm-1 (D) ïŒâãNGâãããâN2âïŒïŒâã¡ãã«âïŒ
âãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ãâ
ïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ãã³é žïŒ ãšãã«ïŒâãNGâãããâN2âïŒïŒâã¡ã
ã«âïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ã
ã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·
ã©ãŒã30ïœããšã¿ããŒã«100mlåã³1Næ°Žé žåã
ããªãŠã 100mlã®æ··å溶åªã«æº¶è§£ãã宀枩ã§24
æéæ¹æåŸã1Nå¡©é žã§äžåããŠã70mlã«ãªã
ãŸã§æ¿çž®ããã ãã®æº¶åªã1Næ°Žé žåãããªãŠã ã§PHïŒ11ã«
調æŽããé ¢é žãšãã«100mlã§ïŒåæŽæµãã1Nå¡©
é žã§é žæ§ã«ããåŸãã¯ãããã«ã 100mlã§ïŒå
æœåºããã åŸãããã¯ãããã«ã æœåºæº¶æ¶²ãç¡æ°Žç¡«é žã
ããªãŠã ã§ä¹Ÿç¥ãã溶åªãçå»ãããšç¡å®åœ¢åº
äœã®ïŒâãNGâãããâN2âïŒïŒâã¡ãã«â
ïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ã
âïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ãã³é ž28.0
ïœïŒ97ïŒ ïŒãåŸãããã I.R.ïŒKBrïŒïŒ3300ïŒ1720ïŒ1630cm-1 å çŽ åæïŒC23H31N7O7Sãšã㊠   èšç®å€ïŒïŒ ïŒ 50.26 5.69 17.84 å®éšå€ïŒïŒ ïŒ 50.00 5.50 17.49 (E) ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒ
âããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒâ
âã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãž
ã³ã«ã«ãã³é žïŒ ïŒâãNGâãããâN2âïŒïŒâã¡ãã«âïŒ
âãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ãâ
ïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ãã³é ž3.00ïœ
ã50mlã®ãšã¿ããŒã«ã«æº¶è§£ãã0.5ïœã®ãã©ãž
ãŠã âãã©ãã¯ãå ããåŸã該混åç©ãæ°ŽçŽ å§
10KgïŒcm2ã®äžã100âã§ïŒæéæ¯çªããã次ã
ã§ã觊åªãå»ãã溶åªãçå»ãããšãç¡å®åœ¢
åºäœã®ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒ
ïŒâããã©ãããâïŒââïŒâãããªã³ã¹ã«ã
ãã«ïŒââã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâ
ãããªãžã³ã«ã«ãã³é ž2.50ïœïŒ90ïŒ ïŒãåŸãã
ãã I.R.ïŒKBrïŒïŒ3400ïŒ1620ïŒ1460ïŒ1380cm-1 NMRïŒ100MHzïŒCD3ODäžã§ã®ÎŽå€ 6.5ïŒtriplet 1HïŒ 7.1ïŒdoublet 1HïŒ 7.4ïŒdoublet 1HïŒ å çŽ åæïŒC23H36N6O5Sãšã㊠   èšç®å€ïŒïŒ ïŒ 54.31 7.13 16.52 å®éšå€ïŒïŒ ïŒ 54.01 6.98 16.61 ãã®ä»åçš®ã®N2âã¢ãªãŒã«ã¹ã«ããã«ââ
ã¢ã«ã®ãã³ã¢ããé¡ãäžèšå®æœäŸã®æ¹æ³ã«åŸã€ãŠ
åæããããã®çµæãè¡šâïŒã«ç€ºãã
ã®ãã³ã¢ããåã³N2âãã³ã·ã«ââã¡ãã«â
âããã«ââã¢ã«ã®ãã³ã¢ããã®LD50å€ã¯ã
ããããã10mgïŒKgãïŒmgïŒKgã§ããã æ¬çºæã®æ²»çå€ã¯ãåç¬ãŸãã¯è¬å€çã«å¯èœãª
æ äœãšè€åããŠã人éãå«ãåºä¹³åç©ã«æäžãã
ãããã®çµæã¯ãååç©ã®æº¶è§£åºŠãååŠçæ§è³ªã
æäžçµè·¯ãæäžèšç»çã«ãã€ãŠæ±ºå®ãããã ããšãã°ãååç©ãéçµå£çã«çèå 泚å°ãé
èå 泚å°ãç®äžæ³šå°ã§æäžããå Žåã溶液ãç匵
ã«ããããã«é£å¡©ãããã¯ã°ã«ã³ãŒã¹çã®ä»ã®æº¶
質ãæ·»å ããç¡è溶液ãšããŠäœ¿çšãããããŸãå
åç©ã¯ãã§ãã·ããä¹³ç³ãçœç³çã®é©åœãªè³Šåœ¢å€
ãå«ãé å€ãã«ãã»ã«å€ãŸãã¯é¡ç²å€ã®åœ¢ã§çµå£
æäžãããããŸãååç©ã«ç³ãã³ãŒã³ã·ãããã
éŠæãè²çŽ çãå ããŠè±æ°ŽæåãåºååããŠãã
ãŒããŸãã¯ããŒã³ãžã®ãããªå£äžé ãšããŠäœ¿çšã
ãããŸã溶液ãšããŠçµå£æäžããå Žåã¯çè²å€ã
ãã³éŠæãå ããã æ¬çºæã®æ²»çå€ã®ã人éã«æé©ãªæäžéã¯ãæ
äžæ³ãååç©ã®çš®é¡ãæ£è ã®ç¶æ ã«ãããå»åž«ã«
ãã€ãŠæ±ºå®ãããã çµå£æäžã§éçµå£æåã§åŸãããã®ãšåçã®å¹
æãåŸãã«ã¯å€§éæäžãå¿ èŠã§ããã æ²»çéã¯äžè¬ã«éçµå£æäžã§æå¹æå10ã50
mgïŒKgïŒæ¥ãçµå£æäžã§10ã500mgïŒKgïŒæ¥ã§ã
ãã 次ã«æ¬çºæååç©ã®è£œæ³ãå®æœäŸã«ãŠããã«å ·
äœçã«èª¬æããããæ¬çºæã¯ãã®èŠæšãè¶ ããªã
éãããããã®å®æœäŸã§åæãããååç©ã«éå®
ãããªãã ãªããæ¬çºæã«ã¯ãæ¬çºæã®ååç©ãæå¹æå
ãšããŠå«ãè¬å€ççµæç©ãå«ãŸããããã®ãããª
çµæç©ã¯äžèšãããããªåœ¢æ ã§ãããç¹ã«æ¬çºæ
ã¯åäžæäžåœ¢åŒã®çµæç©ãå«ãã å®æœäŸ ïŒ (A) ãšãã«ïŒâãNGâãããâN2âïŒtertâã
ããã·ã«ã«ããã«ïŒââã¢ã«ã®ãã«ãâïŒâ
ã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒãïŒ NGâãããâN2âïŒtertâãããã·ã«ã«ã
ãã«ïŒââã¢ã«ã®ãã³28.3ïœã也ç¥ããã©ã
ãããã©ã³450mlã«æº¶è§£ãã溶液ãæ¹æããªã
ããããã«ãããªãšãã«ã¢ãã³9.0ïœåã³ã¯ã
ãã®é žã€ãœããã«12.2ïœãé 次添å ããããã®
æäœã¯ã枩床ãâ20âã«ä¿ã¡ãªããè¡ã€ãã10
ååŸãããã«ããšãã«ïŒâã¡ãã«âïŒâãããª
ãžã³ã«ã«ããã·ã©ãŒã15.2ïœãå ããæ··åç©ã
â20âã§10åéæ¹æãã次ãã§å®€æž©ãŸã§å æž©ã
ãã溶åªãçå»ããæ®çç©ã400mlã®é ¢é žãšã
ã«ã«æº¶è§£ãããã®æº¶æ¶²ã200mlã®æ°Žã100mlã®ïŒ
ïŒ çé žæ°ŽçŽ ãããªãŠã 溶液ã100mlã®10ïŒ ã¯ãš
ã³é žæº¶æ¶²ã200mlã®æ°Žã§é 次æŽæµããåŸãç¡æ°Ž
ç¡«é žãããªãŠã ã§ä¹Ÿç¥ããã 溶åªãçå»ãããšãã·ãããç¶ã®ãšãã«ïŒâ
ãNGâãããâN2âïŒtertâãããã·ã«ã«ãã
ã«ïŒââã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâã
ããªãžã³ã«ã«ããã·ã©ãŒã31.5ïœïŒåç75ïŒ ïŒ
ãåŸãããã I.R.ïŒKBrïŒïŒ3300ïŒ1730ïŒ1680cm-1 (B) ãšãã«ïŒâãNGâãããââã¢ã«ã®ãã«ã
âïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒ
ãå¡©é žå¡©ïŒ ãšãã«ïŒâãNGâãããâN2âïŒtertâã
ããã·ã«ã«ããã«ïŒââã¢ã«ã®ãã«ãâïŒâ
ã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒã30ïœ
ãé ¢é žãšãã«50mlã«æº¶è§£ãã溶液ãæ¹æããªã
ãã80mlã®10ïŒ ä¹Ÿç¥å¡©é žâé ¢é žãšãã«ãå ã
ãããã®æäœã¯ã枩床ãïŒâã«ä¿ã€ãŠè¡ã€ãã
ïŒæéåŸããã®æº¶æ¶²ã«200mlã®ä¹Ÿç¥ãšãã«ãšãŒ
ãã«ãå ãããšãç²çš ãªæ²¹ç¶ç©è³ªãæåºããã
ãããéåŸã也ç¥ãšãã«ãšãŒãã«ã§æŽæµãã
ãšãç¡å®åœ¢åºäœã®ãšãã«ïŒâãNGâãããâ
âã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãž
ã³ã«ã«ããã·ã©ãŒãå¡©é žå¡©ãåŸãããã (C) ãšãã«ïŒâãNGâãããâN2âïŒïŒâã¡ã
ã«âïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ã
ã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·
ã©ãŒãïŒ ãšãã«ïŒâïŒNGâãããââã¢ã«ã®ãã«ïŒ
âïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒ
ãå¡©é žå¡©25ïœã200mlã®ã¯ãããã«ã ã«æº¶è§£ã
ã溶液ãæ¹æããªãããããªãšãã«ã¢ãã³18.5
ïœãšïŒâã¡ãã«âïŒâãããªã³ã¹ã«ããã«ã¯ã
ãªã14.7ïœãé 次添å ããããã®æäœã¯ã枩床
ãïŒâã«ä¿ã€ãŠè¡ã€ããåå¿æ··åç©ã宀枩ã§ïŒ
æéæ¹æããåŸã50mlã®æ°Žã§ïŒåæŽæµããã ãã®ã¯ãããã«ã 溶液ãç¡æ°Žç¡«é žãããªãŠã
ã§ä¹Ÿç¥ããåŸã溶åªãçå»ããæ®çç©ãã·ãªã«
ã²ã«ïŒã¯ãããã«ã äžïŒ50ïœã®ã¯ãããã°ã©ã
ã€ãŒã«ããããã¯ãããã«ã ã§æŽæµåŸãïŒïŒ ã¡
ã¿ããŒã«ãå«ãã¯ãããã«ã ã§ã§æº¶åºãããç»
åãèžçºãããšãç¡å®åœ¢åºäœã®ãšãã«ïŒâ
ãNGâãããâN2âïŒïŒâã¡ãã«âïŒâãã
ãªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ãâïŒâã¡
ãã«âïŒâãããªãžã³ã«ã«ããã·ã©ãŒã32.1ïœ
ãåŸãããã I.R.ïŒKBrïŒïŒ3250ïŒ1725ïŒ1640cm-1 (D) ïŒâãNGâãããâN2âïŒïŒâã¡ãã«âïŒ
âãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ãâ
ïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ãã³é žïŒ ãšãã«ïŒâãNGâãããâN2âïŒïŒâã¡ã
ã«âïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ã
ã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ããã·
ã©ãŒã30ïœããšã¿ããŒã«100mlåã³1Næ°Žé žåã
ããªãŠã 100mlã®æ··å溶åªã«æº¶è§£ãã宀枩ã§24
æéæ¹æåŸã1Nå¡©é žã§äžåããŠã70mlã«ãªã
ãŸã§æ¿çž®ããã ãã®æº¶åªã1Næ°Žé žåãããªãŠã ã§PHïŒ11ã«
調æŽããé ¢é žãšãã«100mlã§ïŒåæŽæµãã1Nå¡©
é žã§é žæ§ã«ããåŸãã¯ãããã«ã 100mlã§ïŒå
æœåºããã åŸãããã¯ãããã«ã æœåºæº¶æ¶²ãç¡æ°Žç¡«é žã
ããªãŠã ã§ä¹Ÿç¥ãã溶åªãçå»ãããšç¡å®åœ¢åº
äœã®ïŒâãNGâãããâN2âïŒïŒâã¡ãã«â
ïŒâãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ã
âïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ãã³é ž28.0
ïœïŒ97ïŒ ïŒãåŸãããã I.R.ïŒKBrïŒïŒ3300ïŒ1720ïŒ1630cm-1 å çŽ åæïŒC23H31N7O7Sãšã㊠   èšç®å€ïŒïŒ ïŒ 50.26 5.69 17.84 å®éšå€ïŒïŒ ïŒ 50.00 5.50 17.49 (E) ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒ
âããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒâ
âã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãž
ã³ã«ã«ãã³é žïŒ ïŒâãNGâãããâN2âïŒïŒâã¡ãã«âïŒ
âãããªã³ã¹ã«ããã«ïŒââã¢ã«ã®ãã«ãâ
ïŒâã¡ãã«âïŒâãããªãžã³ã«ã«ãã³é ž3.00ïœ
ã50mlã®ãšã¿ããŒã«ã«æº¶è§£ãã0.5ïœã®ãã©ãž
ãŠã âãã©ãã¯ãå ããåŸã該混åç©ãæ°ŽçŽ å§
10KgïŒcm2ã®äžã100âã§ïŒæéæ¯çªããã次ã
ã§ã觊åªãå»ãã溶åªãçå»ãããšãç¡å®åœ¢
åºäœã®ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒ
ïŒâããã©ãããâïŒââïŒâãããªã³ã¹ã«ã
ãã«ïŒââã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâ
ãããªãžã³ã«ã«ãã³é ž2.50ïœïŒ90ïŒ ïŒãåŸãã
ãã I.R.ïŒKBrïŒïŒ3400ïŒ1620ïŒ1460ïŒ1380cm-1 NMRïŒ100MHzïŒCD3ODäžã§ã®ÎŽå€ 6.5ïŒtriplet 1HïŒ 7.1ïŒdoublet 1HïŒ 7.4ïŒdoublet 1HïŒ å çŽ åæïŒC23H36N6O5Sãšã㊠   èšç®å€ïŒïŒ ïŒ 54.31 7.13 16.52 å®éšå€ïŒïŒ ïŒ 54.01 6.98 16.61 ãã®ä»åçš®ã®N2âã¢ãªãŒã«ã¹ã«ããã«ââ
ã¢ã«ã®ãã³ã¢ããé¡ãäžèšå®æœäŸã®æ¹æ³ã«åŸã€ãŠ
åæããããã®çµæãè¡šâïŒã«ç€ºãã
ãè¡šã
ãè¡šã
å®æœäŸïŒ çµå£æäžçšé å€
åžžæ³ã«åŸã€ãŠãäžèšè¡šã«ç€ºãæåãå«ãé å€ã
調補ããããšãã§ããã
調補ããããšãã§ããã
ãè¡šã
å®æœäŸïŒ çµå£æäžçšã«ãã»ã«å€
äžèšè¡šã«ç€ºãæåãããæ··åããŠãŒã©ãã³ã«ã
ã»ã«ã«ã€ããã«ãã»ã«å€ã調補ããã
ã»ã«ã«ã€ããã«ãã»ã«å€ã調補ããã
ãè¡šã
å®æœäŸïŒ 泚å°çšç¡è溶液
äžèšè¡šã«ç€ºãæåãæ··åããŠæº¶æ¶²ãšãã殺èã
ãŠãéèå 泚å°çšæº¶æ¶²ã調補ããã
ãŠãéèå 泚å°çšæº¶æ¶²ã調補ããã
ãè¡šã
å®æœäŸ ïŒ
æ¬çºæååç©ã®çµå£æäžã«ãããŠãµã®é åèè¡
æ ã®çææå¶å¹æ å®æœäŸïŒã®æ¹æ³ã«ãã€ãŠåŸãããè¡šâïŒã®åå
ç©No.ïŒãå¡©é žé žæ§æº¶æ¶²ïŒPHïŒãïŒïŒãšããŠïŒæ¥é
絶é£ããéæ§ãŠãµã®ïŒäœé2.6ã2.9KgïŒ10å¹ã®ã
ã¡åæ°ã«ã¯10mgïŒKgãæ®ãã®åæ°ã«ã¯40mgïŒKgã®
å²åã§çµå£æäžãããæäž30ååŸã«ãŠãµã®ã®é éš
ãåéããäž¡åŽã®é åèãé²åºãããé·ãïŒcmã®
è±è綿ã§å·»ãããã«å ã¿ããã®å€åŽãããªãšãã¬
ã³è£œã«ãã»ã«ã§ã«ããŒããããã®ã«ãã»ã«å ã®è±
è綿ã«90ïŒ é ¢é žæº¶æ¶²ãååã«æµžã¿èŸŒãŸããïŒæé
æŸçœ®åŸãè¡ç®¡ãåãåºããé·è»žæ¹åã«åéããŠã
å®äœé¡åŸ®é¡äžã§ããé ¢é žã§æå·ãããè¡ç®¡å£ã®å š
é¢ç©ãã«å¯Ÿãããè¡æ ãå ããé¢ç©ãã®å²åãæ±
ããŠãè¡æ ã®å€§ãããå€å®ãããè¡æ ã®å€§ããã¯
次ã®ïŒæ®µéã«åé¡ããã ïŒéå¡è¡æ ïŒè¡æ ã®å ããå²åã70ïŒ ä»¥äžã§éå¡ããŠã
ãªã倧ããè¡æ ïŒïŒè¡æ ã®å ããå²åã31ã69ïŒ ä»¥äžã§äžçšåºŠ
ã®è¡æ ïŒè¡æ ã®å ããå²åã30ïŒ ä»¥äžã®å°ããè¡æ ïŒè¡æ ãå šãèªããããªããã® æ¯èŒååç©ãšããŠãååç©No.ïŒãšã¯äžè¬åŒ
ïŒïŒäžã®Arã®éšåã«ãããŠç°ãªãååç©ãããª
ãã¡Arã
æ ã®çææå¶å¹æ å®æœäŸïŒã®æ¹æ³ã«ãã€ãŠåŸãããè¡šâïŒã®åå
ç©No.ïŒãå¡©é žé žæ§æº¶æ¶²ïŒPHïŒãïŒïŒãšããŠïŒæ¥é
絶é£ããéæ§ãŠãµã®ïŒäœé2.6ã2.9KgïŒ10å¹ã®ã
ã¡åæ°ã«ã¯10mgïŒKgãæ®ãã®åæ°ã«ã¯40mgïŒKgã®
å²åã§çµå£æäžãããæäž30ååŸã«ãŠãµã®ã®é éš
ãåéããäž¡åŽã®é åèãé²åºãããé·ãïŒcmã®
è±è綿ã§å·»ãããã«å ã¿ããã®å€åŽãããªãšãã¬
ã³è£œã«ãã»ã«ã§ã«ããŒããããã®ã«ãã»ã«å ã®è±
è綿ã«90ïŒ é ¢é žæº¶æ¶²ãååã«æµžã¿èŸŒãŸããïŒæé
æŸçœ®åŸãè¡ç®¡ãåãåºããé·è»žæ¹åã«åéããŠã
å®äœé¡åŸ®é¡äžã§ããé ¢é žã§æå·ãããè¡ç®¡å£ã®å š
é¢ç©ãã«å¯Ÿãããè¡æ ãå ããé¢ç©ãã®å²åãæ±
ããŠãè¡æ ã®å€§ãããå€å®ãããè¡æ ã®å€§ããã¯
次ã®ïŒæ®µéã«åé¡ããã ïŒéå¡è¡æ ïŒè¡æ ã®å ããå²åã70ïŒ ä»¥äžã§éå¡ããŠã
ãªã倧ããè¡æ ïŒïŒè¡æ ã®å ããå²åã31ã69ïŒ ä»¥äžã§äžçšåºŠ
ã®è¡æ ïŒè¡æ ã®å ããå²åã30ïŒ ä»¥äžã®å°ããè¡æ ïŒè¡æ ãå šãèªããããªããã® æ¯èŒååç©ãšããŠãååç©No.ïŒãšã¯äžè¬åŒ
ïŒïŒäžã®Arã®éšåã«ãããŠç°ãªãååç©ãããª
ãã¡Arã
ãåŒãã§ãããã®ïŒæ¯èŒåå
ç©ïœïŒåã³
ãåŒãã§ãããã®
ïŒæ¯èŒååç©ïœïŒãæäžããŠäžèšãšåæ§ã®æäœã
è¡ãªããè¡æ ã®å€§ãããæ±ããã ãã®çµæãè¡šâïŒã«ç€ºãã
è¡ãªããè¡æ ã®å€§ãããæ±ããã ãã®çµæãè¡šâïŒã«ç€ºãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžèšäžè¬åŒïŒïŒ ïŒäžèšäžè¬åŒïŒïŒäžã§ãã¯
ãåŒãã瀺ããR1ã¯ãæ°ŽçŽ ååãã ãã¯C1ãC5ã¢ã«ãã«åºã瀺ãããŸããArã¯ïŒäœ
ãã¡ãã«åºåã¯ãšãã«åºã§çœ®æãããïŒïŒïŒïŒ
ïŒïŒïŒâããã©ãããâïŒâãããªã«åºã瀺ããïŒ
ã§è¡šããããN2âã¢ãªãŒã«ã¹ã«ããã«ââã¢
ã«ã®ãã³ã¢ããé¡åã³è¬å€ãšããŠèš±å®¹ããåŸãã
ã®å¡©ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®äžè¬åŒïŒïŒã«
ãããŠãR1ããæ°ŽçŽ ååãããã¯C1ãC3ã¢ã«ã
ã«åºã§ããN2âã¢ãªãŒã«ã¹ã«ããã«ââã¢ã«
ã®ãã³ã¢ããé¡åã³è¬å€ãšããŠèš±å®¹ããåŸããã®
å¡©ã ïŒ ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒ
âããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒâ
âã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«
ã«ãã³é žã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒâãN2âïŒïŒâã¡ãã«âïŒïŒïŒïŒïŒïŒïŒ
âããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒâ
âã¢ã«ã®ãã«ãâïŒâãšãã«âïŒâãããªãžã³ã«
ã«ãã³é žã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒâãN2âïŒïŒâãšãã«âïŒïŒïŒïŒïŒïŒïŒ
âããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒâ
âã¢ã«ã®ãã«ãâïŒâã¡ãã«âïŒâãããªãžã³ã«
ã«ãã³é žã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒâãN2âïŒïŒâãšãã«âïŒïŒïŒïŒïŒïŒïŒ
âããã©ãããâïŒâãããªã³ã¹ã«ããã«ïŒâ
âã¢ã«ã®ãã«ãâïŒâãšãã«âïŒâãããªãžã³ã«
ã«ãã³é žã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/938,711 US4201863A (en) | 1974-11-08 | 1978-08-31 | N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5533499A JPS5533499A (en) | 1980-03-08 |
| JPH0135000B2 true JPH0135000B2 (ja) | 1989-07-21 |
Family
ID=25471841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11091179A Granted JPS5533499A (en) | 1978-08-31 | 1979-08-30 | N2-arylsulfonyl-l-arginineamide and its pharmaceutically acceptable salt |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS5533499A (ja) |
| SU (1) | SU1042615A3 (ja) |
| ZA (1) | ZA794581B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5782314A (en) * | 1980-11-13 | 1982-05-22 | Mitsubishi Chem Ind Ltd | Carcinostatic agent |
| JP4674339B2 (ja) * | 1998-08-07 | 2011-04-20 | äžè±ååŠæ ªåŒäŒç€Ÿ | è³æå·ã®äºé²ã»æ²»çå€ |
| JP2007332093A (ja) * | 2006-06-16 | 2007-12-27 | Apro Life Science Institute Inc | ã¿ã³ãã¯è³ªã®ãªãã©ãŒã«ãã£ã³ã°æ·»å å€åã³ãããçšããã¿ã³ãã¯è³ªã®åçæ¹æ³ |
| ITPD20080106A1 (it) * | 2008-04-07 | 2009-10-08 | Lundbeck Pharmaceuticals Italy Spa | Metodo di preparazione di argatroban monoidrato |
| ITMI20110545A1 (it) | 2011-04-04 | 2012-10-05 | Lundbeck Pharmaceuticals Italy S P A | Metodo per la preparazione di intermedi di processo per la sintesi di argatroban monoidrato |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5297934A (en) * | 1975-12-09 | 1977-08-17 | Mitsubishi Chem Ind Ltd | N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s |
| DE2801478A1 (de) * | 1977-01-19 | 1978-07-20 | Mitsubishi Chem Ind | N hoch 2 -arylsulfonyl-l-argininamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
-
1979
- 1979-08-30 SU SU792814248A patent/SU1042615A3/ru active
- 1979-08-30 ZA ZA00794581A patent/ZA794581B/xx unknown
- 1979-08-30 JP JP11091179A patent/JPS5533499A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5297934A (en) * | 1975-12-09 | 1977-08-17 | Mitsubishi Chem Ind Ltd | N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s |
| DE2801478A1 (de) * | 1977-01-19 | 1978-07-20 | Mitsubishi Chem Ind | N hoch 2 -arylsulfonyl-l-argininamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
Also Published As
| Publication number | Publication date |
|---|---|
| SU1042615A3 (ru) | 1983-09-15 |
| ZA794581B (en) | 1981-04-29 |
| JPS5533499A (en) | 1980-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0008746B1 (en) | Alpha-(n-arylsulfonyl-l-argininamides, processes for their preparation and pharmaceutical compositions containing these substances | |
| US4258192A (en) | N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| US4073914A (en) | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| US4018913A (en) | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| US4041156A (en) | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| US4055651A (en) | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| US4201863A (en) | N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| EP0822931A1 (en) | Piperazinones useful as inhibitors of platelet aggregation | |
| US4820730A (en) | 6-amino-2-naphthyl 4-gusnichinobenzoate derivatives and pharmaceutical composition containing them | |
| US4071621A (en) | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| JPH0135000B2 (ja) | ||
| JPH0259145B2 (ja) | ||
| US4490388A (en) | Amidine compound and anticomplement agent comprising same | |
| JP3387948B2 (ja) | æ°èŠãªãã§ãã«ã¢ã©ãã³èªå°äœãŸãã¯ãã®å¡© | |
| US4073916A (en) | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof | |
| SE452624B (sv) | Sett att framstella n?722-arylsulfonyl-l-argininamider och farmaceutiskt godtagbara salter derav | |
| WO2000004001A1 (fr) | Piperazinones substituees et leurs applications en therapeutique | |
| KR820002084B1 (ko) | N²-ì늎ì€í¬ë-l-ìêž°ëìë§ìŽë ì ë첎ì ì ì¡°ë°©ë² | |
| JPH0231055B2 (ja) | ||
| JPS6148829B2 (ja) | ||
| EP0823430A1 (en) | Method for preparing n2-arylsulfonyl-l-argininamides | |
| JP2023084946A (ja) | çç掻æ§ãæããæ°èŠååç© | |
| JPH09157236A (ja) | ãã§ãã¬ã³ãžã¢ãã³èªå°äœåã³ã©ãžã«ã«ã¹ã«ãã³ãžã£ãŒãè³æ¢å¡æå¶å€ãè³æµ®è «æå¶å€ | |
| JPH10101649A (ja) | ïŒ®ïŒ âã¢ãªãŒã«ã¹ã«ããã«âïœâã¢ã«ã®ãã³ã¢ããé¡ã®è£œé æ¹æ³ | |
| JP2023084944A (ja) | çç掻æ§ãæããæ°èŠååç© |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |